Biogen's Empaveli cuts proteinuria 75% in teens with rare kidney disease
Biogen Inc. (Nasdaq: BIIB) announced the publication of results from a prespecified adolescent subgroup analysis ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)

